Levi Garraway
Tracked across 4 events · 53 articles · First seen Apr 21, 2026 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Roche has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics to co-develop and co-commercialize bexobrutideg (also known as NX-5948), an investigational Bruton's Tyrosine Kinase (BTK) degrader. Roche will pay Nurix Therapeutics an…
Impact: Levi Garraway, Roche's chief medical officer, expressed confidence in bexobrutideg's potential to significantly advance treatment for complex blood cancers and other diseases, highlighting Roche's strategic vision for the drug.
Jun 07, 2026 · 22 articles
Tech
F. Hoffmann-La Roche — Genentech>>>, a member of the Roche Group, announced that the United States — Food and Drug Administration>>> (FDA) has accepted its New Drug Application (NDA) for giredestrant under Priority Review. Giredestrant…
Impact: Levi Garraway>>>, chief medical officer at F. Hoffmann-La Roche — Genentech>>>, provided commentary on the significance of giredestrant as a major advance in endocrine therapy for early-stage ER-positive breast cancer.
Jun 02, 2026 · 6 articles
Tech
F. Hoffmann-La Roche — Genentech, a member of the Roche Group, announced new data from its obesity portfolio will be presented at the 2026 Scientific Sessions of the American Diabetes Association. The data highlights significant…
Impact: Levi Garraway, as the chief medical officer and head of Global Product Development at F. Hoffmann-La Roche — Genentech, commented on the strength of the obesity portfolio and the potential for individualized treatment options.
May 27, 2026 · 19 articles
Regulatory
Roche>>> announced that the United States — Food and Drug Administration>>> has accepted its supplemental Biologics License Application (sBLA) for adjuvant Atezolizumab>>> and Atezolizumab Hybreza in combination with chemotherapy for stage III deficient DNA mismatch…
Impact: Levi Garraway>>>, Roche>>>'s Chief Medical Officer, commented on the significance of the filing acceptance for Atezolizumab>>>.
Jun 11, 2026 · 6 articles
NEWSDESK
Track Levi Garraway live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard